I Holland Helps to Solve Tablet Sticking Problems with an In-Depth Webinar
![](/46/pdcnewsitem/03/42/54/PiHvxtaweNOvjt9.jpg)
I Holland will share its knowledge and expertise on the production of tablets in an hour long webinar on 26 March, giving visitors the opportunity to ask questions on how to maximise tooling productivity.
With 70 years' experience in providing innovative tablet tooling and complimentary equipment, I Holland is well placed to answer any questions visitors may have on how they can boost their productivity in the tabletting sector.
Rob Blanchard, I Holland R&D Manager, along with a panel of experts, will answer any questions put forward to help tablet manufacturers get the most out of their production with a direct question and answer webinar session. "Tablet manufacture is an ever changing environment which requires changes to respond to this evolvement. Sometimes the productivity and efficiency of traditional tablet manufacturing does not produce the required end result, and innovative approaches are needed," explains Rob.
"I Holland has worked hard to understand tabletting science and has extensive experience and research in the best methods to produce an end product which meets expectations. We have held a series of webinars, including '"Increase Tablet Production and Efficiency with Successful Implementation", "Solving your Sticking Problems with Tabletting Science", "Good Tablet Design" and "How a Punch and Die Maintenance SOP Improves your Profitability and Productivity" and were overwhelmed by the response.
"We discovered that visitors wanted more time to ask questions that really got to the root of how they could maximise profitability through improved productivity. We have a number of innovative product developments and studies that continue to transform the way pharmaceutical manufacture is undertaken, making it a process that is fast, precise, reliable. With this knowledge we can help our customers in their quest to deliver annual cost reductions while maintaining exacting standards of quality. We hope that the webinar will provide answers to production questions to give a better understanding of the process."
The webinar "How to Maximise Tooling Productivity" is open to all, with registration available on the I Holland website, and will be held at 2 pm on 26 March. To ask any questions you may have on improving tooling productivity in the pharmaceutical and nutraceuticals sectors please visit www.tablettingscience.com
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance